Autobio Diagnostics Co Ltd
SSE:603658

Watchlist Manager
Autobio Diagnostics Co Ltd Logo
Autobio Diagnostics Co Ltd
SSE:603658
Watchlist
Price: 44.2 CNY -6.04% Market Closed
Market Cap: 25.3B CNY
Have any thoughts about
Autobio Diagnostics Co Ltd?
Write Note

Autobio Diagnostics Co Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Autobio Diagnostics Co Ltd
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Autobio Diagnostics Co Ltd
SSE:603658
Current Portion of Long-Term Debt
ÂĄ300.3m
CAGR 3-Years
213%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Current Portion of Long-Term Debt
ÂĄ673.9m
CAGR 3-Years
-9%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Current Portion of Long-Term Debt
ÂĄ92.1m
CAGR 3-Years
N/A
CAGR 5-Years
73%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Current Portion of Long-Term Debt
ÂĄ222.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Current Portion of Long-Term Debt
ÂĄ1.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Intco Medical Technology Co Ltd
SZSE:300677
Current Portion of Long-Term Debt
ÂĄ11.2m
CAGR 3-Years
-53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Autobio Diagnostics Co Ltd
Glance View

Market Cap
25.7B CNY
Industry
Health Care

Autobio Diagnostics Co., Ltd. engages in the research, development, manufacturing, integration, service, and distribution of in vitro diagnostic reagents and instruments. The company is headquartered in Zhengzhou, Henan and currently employs 5,031 full-time employees. The company went IPO on 2016-09-01. The firm's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The firm distributes its products in domestic markets.

Intrinsic Value
78.4 CNY
Undervaluation 44%
Intrinsic Value
Price

See Also

What is Autobio Diagnostics Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
300.3m CNY

Based on the financial report for Jun 30, 2024, Autobio Diagnostics Co Ltd's Current Portion of Long-Term Debt amounts to 300.3m CNY.

What is Autobio Diagnostics Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 3Y
213%

Over the last year, the Current Portion of Long-Term Debt growth was -2%. The average annual Current Portion of Long-Term Debt growth rates for Autobio Diagnostics Co Ltd have been 213% over the past three years .

Back to Top